If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates provides myopia control right here in West Chester, with both FDA-approved MiSight contact lenses and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, not an optometry-only office, so if anything beyond myopia ever comes up, expert care is already in place.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by genuine pediatric eye specialists, not a general optical shop.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
Unlike a standalone optometry office, we are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, surgical-level expertise is already part of their care.
Parents in West Chester frequently ask us about a treatment that does not require their child to handle a contact lens at all: a small drop placed in each eye at bedtime. Low-dose atropine has become one of the most discussed approaches to slowing childhood myopia, and for the right child it can be a straightforward and well-tolerated option. Our office is right here in West Chester, and an atropine consultation is a common reason local families come to see us.
Atropine is a long-established eye medication. At the very low concentrations used for myopia control, commonly between 0.01% and 0.05%, it is used off-label to slow the elongation of a child's eye over time. This is a different purpose and a far weaker strength than the dilating drops used during a routine eye exam, which is why the everyday side effects most people associate with atropine are usually minimal at these low doses.
The appeal for many West Chester parents is the simplicity. A single drop is placed in each eye at night, often as part of the bedtime routine, and the child wears their normal glasses during the day. There are no lenses to insert, clean, or store. Because the dose is low, many children notice little to no change in how their eyes feel, though some may experience slight light sensitivity or a small effect on close focus, which we monitor and can adjust for by changing the concentration.
One reason atropine works well as a managed, primary treatment is that the strength can be tailored. We may begin at a lower concentration and adjust based on how a child's prescription responds over the following months. This is not a set-and-forget medication; it is a plan that Dr. Mudgil and our optometric team revisit at follow-up visits, watching both the rate of progression and how comfortably the child tolerates the drop.
Atropine is one of several tools, and sometimes it is used alongside others. MiSight 1 day contact lenses, FDA-approved to slow progression in children roughly ages 8 to 12, suit families comfortable with daily lens wear. Orthokeratology offers overnight lens reshaping. Atropine often becomes the lead choice for younger children, for kids not yet ready for contacts, or for families who simply prefer a drop. Slowing progression with any of these methods matters because higher myopia carries greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.
It is used off-label for this purpose. The low concentrations have a long track record in eye care.
At low concentrations, effects are usually mild. We can lower the concentration if a child is bothered.
Often yes, which is part of why it is a popular first choice for younger kids.
We discuss timing carefully, since stopping is something to plan with us rather than do abruptly.
Most West Chester families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.